RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development

Drug Metabolism and Disposition

Volumn 40, Issue 6, 2012, Pages 1198-1209

  Peng, Lai ^a   Yoo, Byunggil ^b   Gunewardena, Sumedha S ^b   Lu, Hong ^c   Klaassen, Curtis D ^a   Zhong, Xiao Bo ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b Kansas Intellectual and Developmental Disabilities Research Center   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2E; CYTOCHROME P450 2F; CYTOCHROME P450 3A; CYTOCHROME P450 4A; CYTOCHROME P450 4F; MESSENGER RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CYTOCHROME P450 1A GENE; CYTOCHROME P450 26B1 GENE; CYTOCHROME P450 2A GENE; CYTOCHROME P450 2B GENE; CYTOCHROME P450 2B10 GENE; CYTOCHROME P450 2C GENE; CYTOCHROME P450 2C44 GENE; CYTOCHROME P450 2C50 GENE; CYTOCHROME P450 2D GENE; CYTOCHROME P450 2D22 GENE; CYTOCHROME P450 2D26 GENE; CYTOCHROME P450 2E GENE; CYTOCHROME P450 2F GENE; CYTOCHROME P450 3A GENE; CYTOCHROME P450 3A13 GENE; CYTOCHROME P450 3A25 GENE; CYTOCHROME P450 4A GENE; CYTOCHROME P450 4F GENE; CYTOCHROME P450 GENE; DOWN REGULATION; ENZYME INDUCTION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; LIVER DEVELOPMENT; MALE; MOLECULAR DYNAMICS; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RNA SEQUENCE;

ALTERNATIVE SPLICING; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIVER; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PREGNANCY; RNA SPLICING; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS;

EID: 84862094706     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.045088     Document Type: Article

References (33)

1. Alcorn J, Elbarbry FA, Allouh MZ, and McNamara PJ (2007) Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome P450 activity. Drug Metab Dispos 35:2225-2231. (Pubitemid 350146209)
2. Apte U, Zeng G, Thompson MD, Muller P, Micsenyi A, Cieply B, Kaestner KH, and Monga SP (2007) β-Catenin is critical for early postnatal liver growth. Am J Physiol Gastrointest Liver Physiol 292:G1578-G1585. (Pubitemid 47080611)
3. Benjamini Y and Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
4. Blake MJ, Castro L, Leeder JS, and Kearns GL (2005) Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123-138. (Pubitemid 40215540)
5. Cherala G, Shapiro BH, and D'mello AP (2007) Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome P450 enzymes and cytochrome P450 reductase in the rat. Drug Metab Dispos 35:1057-1063. (Pubitemid 46956424)
6. Choudhary D, Jansson I, Sarfarazi M, and Schenkman JB (2004) Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective. Drug Metab Rev 36:549-568. (Pubitemid 39453062)
7. Danielson PB (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3:561-597.
8. Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70-83.
9. Hart SN, Cui Y, Klaassen CD, and Zhong XB (2009) Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos 37:116-121.
10. Hines RN (2007) Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21:169-175.
11. Hines RN (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250-267.
12. Hines RN and McCarver DG (2002) The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300:355-360. (Pubitemid 34106223)
13. Hrycay EG and Bandiera SM (2009) Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes. Curr Drug Metab 10:1151-1183.
14. Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, and Talianidis I (2006) Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 20:2293-2305.
15. Leeder JS, Gaedigk R, Marcucci KA, Gaedigk A, Vyhlidal CA, Schindel BP, and Pearce RE (2005) Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 314:626-635. (Pubitemid 41043843)
16. Li D, Gaedigk R, Hart SN, Leeder JS, and Zhong XB (2012) The role of CYP3A4 mRNA transcript with shortened 3′-untranslated region in hepatocyte differentiation, liver development, and response to drug induction. Mol Pharmacol 81:86-96.
17. Li T, Huang J, Jiang Y, Zeng Y, He F, Zhang MQ, Han Z, and Zhang X (2009a) Multi-stage analysis of gene expression and transcription regulation in C57/B6 mouse liver development. Genomics 93:235-242.
18. Li Y, Cui Y, Hart SN, Klaassen CD, and Zhong XB (2009b) Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol 75:1171-1179.
19. Malone JH and Oliver B (2011) Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol 9:34.
20. Mortazavi A, Williams BA, McCue K, Schaeffer L, and Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621-628. (Pubitemid 351911867)
21. Muruganandan S and Sinal CJ (2008) Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism. Clin Pharmacol Ther 83:818-828. (Pubitemid 351704925)
22. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, and Snyder M (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320:1344-1349. (Pubitemid 351929471)
23. Nebert DW and Gonzalez FJ (1987) P450 genes: structure, evolution, and regulation. Annu Rev Biochem 56:945-993.
24. Pan Q, Shai O, Lee LJ, Frey BJ, and Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413-1415.
25. Pearce RE, Gotschall RR, Kearns GL, and Leeder JS (2001) Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug Metab Dispos 29:1548-1554. (Pubitemid 33111587)
26. Pesole G, Grillo G, Larizza A, and Liuni S (2000) The untranslated regions of eukaryotic mRNAs: structure, function, evolution and bioinformatic tools for their analysis. Brief Bioinform 1:236-249.
27. Rowell M and Zlotkin S (1997) The ethical boundaries of drug research in pediatrics. Pediatr Clin North Am 44:27-40. (Pubitemid 27102454)
28. Schuetz JD, Beach DL, and Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20.
29. Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, and Zaya MJ (2003) Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573-582. (Pubitemid 37310671)
30. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, and Pachter L (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511-515.
31. Tréluyer JM, Rey E, Sonnier M, Pons G, and Cresteil T (2001) Evidence of impaired cisapride metabolism in neonates. Br J Clin Pharmacol 52:419-425. (Pubitemid 32939444)
32. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, and Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476. (Pubitemid 352759009)
33. Wang Z, Gerstein M, and Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57-63.